欧康维视提示

本内容仅供医学专业人士使用。如果您是医学专业人士,请点击确认,进入页面;否则请点击退出,返回上一页。
Home/Investors/Public Disclosure/Announcements and Circulars
Announcements and Circulars
2024-05-23
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, JUNE 20, 2024
2024-05-23
NOTICE OF ANNUAL GENERAL MEETING
2024-05-23
PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; PROPOSED RE-ELECTION OF RETIRING DIRECTORS; PROPOSED RE-APPOINTMENT OF AUDITOR; PROPOSED AMENDMENTS TO THE 2021 SHARE OPTION SCHEME; PROPOSED AMENDMENTS TO THE 2021 SHARE AWARD SCHEME; AND NOTICE OF ANNUAL GENERAL MEETING
2024-05-23
Documents on Display Multi-Files
2024-05-21
Next Day Disclosure Return
2024-05-06
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 April 2024
2024-04-25
2023 Annual Report
2024-04-25
2023 Environmental, Social and Governance Report
2024-04-15
VOLUNTARY ANNOUNCEMENT PRIMARY ENDPOINTS ACHIEVED IN THE PHASE III CLINICAL TRIAL OF OT-502 IN CHINA
2024-04-08
VOLUNTARY ANNOUNCEMENT COMPLETION OF THE PHASE III CLINICAL TRIAL OF OT-702 IN CHINA
2024-04-03
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 March 2024
2024-03-22
(I) PROPOSED AMENDMENTS TO THE 2021 SHARE OPTION SCHEME; AND (II) PROPOSED AMENDMENTS TO THE 2021 SHARE AWARD SCHEME
2024-03-21
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
2024-03-14
VOLUNTARY ANNOUNCEMENT PRIMARY ENDPOINTS ACHIEVED IN THE PHASE II CLINICAL TRIAL OF OT-202
2024-03-07
DATE OF BOARD MEETING
2024-03-01
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 29 February 2024
2024-02-09
Notification Letter to Registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications
2024-02-09
Notification Letter to Non-registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications
2024-02-01
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 January 2024
2024-01-19
Next Day Disclosure Return
2024-01-18
Next Day Disclosure Return
2024-01-17
Next Day Disclosure Return
2024-01-17
DISCLOSEABLE TRANSACTION DISPOSAL OF SHARES IN EYEPOINT PHARMACEUTICALS, INC.
2024-01-16
Next Day Disclosure Return
2024-01-15
Next Day Disclosure Return
2024-01-12
Next Day Disclosure Return
2024-01-11
Next Day Disclosure Return (Resubmission)
2024-01-11
Next Day Disclosure Return (Resubmission)
2024-01-10
Next Day Disclosure Return
2024-01-09
Next Day Disclosure Return
2024-01-08
Next Day Disclosure Return
2024-01-05
Next Day Disclosure Return
2024-01-04
Next Day Disclosure Return
2024-01-03
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 December 2023
2024-01-03
Next Day Disclosure Return
2024-01-02
Next Day Disclosure Return
Follow us